| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS LP reports a 6.5% stake in PDL BioPharma Inc |
| 02/08/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/26/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 02/19/2021 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/04/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2021 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 187,061 shares
@ $2.05, valued at
$383.5k
|
|
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/02/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/01/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/01/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/15/2021 |
SC TO-I
| Form SC TO-I - Tender offer statement by Issuer: |
| 01/11/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 01/11/2021 |
3
| Park West Asset Management LLC (10% Owner) has filed a Form 3 on PDL BIOPHARMA, INC. |
| 01/11/2021 |
SC 13G/A
| Park West Asset Management LLC reports a 12.6% stake in PDL Biopharma, inc. |
| 01/08/2021 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Silver Point Capital L.P. (10% Owner) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Bought 128,000 shares
@ $2.65, valued at
$339.2k
Bought 235,000 shares
@ $2.7, valued at
$634.5k
Bought 268,600 shares
@ $2.69, valued at
$722.5k
|
|
|